Evaluation of six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trial
暂无分享，去创建一个
M. Atkins | U. Dafni | J. Kirkwood | H. Gogas | C. Markopoulos | G. Fountzilas | E. Buchbinder | A. Polyzos | M. Spyropoulou-Vlachou | D. Tsoutsos | A. Stratigos | O. Castana | H. Koon | Y. Metaxas | P. Panagiotou | E. Pectasides | P. Skarlos